Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: Keratinocytes in atopic dermatitis - Their pathogenic involvement

Journal of Pharmacological Sciences

Volumn 110, Issue 3, 2009, Pages 260-264

  Komine, Mayumi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Allergic inflammation; Atopic dermatitis; Cytokine chemokine; Epidermal barrier; Keratinocyte; Proteinase

Indexed keywords

CHEMOKINE; CYTOKINE; FILAGGRIN; PROTEINASE; THYMIC STROMAL LYMPHOPOIETIN;

ATOPIC DERMATITIS; CONFERENCE PAPER; DISEASE COURSE; HUMAN; KERATINOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN ALLERGY;

EID: 67749106327     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09R06FM     Document Type: Conference Paper

References (29)

1. Furue M, Furukawa F, Hide M, Takehara K. Guidelines for therapy for atopic dermatitis 2004. Jpn J Dermatol. 2004;114: 135-142.
2. Fartasch M, Haneke E, Anton-Lamprecht I. Ultrastructural study of the occurrence of autosomal dominant ichthyosis vulgaris in atopic eczema. Arch Dermatol Res. 1987;279:270-272. (Pubitemid 17089446)
3. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441-446.
4. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol. 2005;6:328-340. (Pubitemid 40516899)
5. Seguchi T, Cui CY, Kusuda S, Takahashi M, Aisu K, Tezuka T. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res. 1996;288:442-446. (Pubitemid 26282737)
6. Sugiura H, Ebise H, Tazawa T, Tanaka K, Sugiura Y, Uehara M, et al. Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol. 2005; 152:146-149. (Pubitemid 40193847)
7. Cookson WO, Ubhi B, Lawrence R, Abecasis GR, Walley AJ, Cox HE, et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet. 2001;27:372-373. (Pubitemid 32268416)
8. Palmer CN, Ismail T, Lee SP, Terron-Kwiatkowski A, Zhao Y, Liao H, et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. J Allergy Clin Immunol. 2007;120:64-68. (Pubitemid 46990494)
9. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest. 1998;101:1614-1622. (Pubitemid 28198490)
10. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet. 2000;25:141-142. (Pubitemid 30394980)
11. Hansson L, Bäckman A, Ny A, Edlund M, Ekholm E, Ekstrand Hammarström B, et al. Epidermal overexpression of stratum corneum chymotryptic enzyme in mice: a model for chronic itchy dermatitis. J Invest Dermatol. 2002;118:444-449. (Pubitemid 34227161)
12. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol. 2006;118:3-21. (Pubitemid 43946484)
13. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347:1151-1160.
14. Tanaka T, Tsutsui H, Yoshimoto T, Kotani M, Matsumoto M, Fujita A, et al. Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/ Nga. Int Arch Allergy Immunol. 2001;125:236-240.
15. Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol. 2001;107:535-541. (Pubitemid 32210037)
16. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol. 2001;117:977-983. (Pubitemid 33001220)
17. Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka K, Tanaka M, et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/ stat6 under specific pathogenfree conditions. Proc Natl Acad Sci U S A. 2002;99:11340-11345. (Pubitemid 34920927)
18. Tsunemi Y, Saeki H, Nakamura K, Nagakubo D, Nakayama T, Yoshie O, et al. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli. Eur J Immunol. 2006;36:2116-2127. (Pubitemid 44251757)
19. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med. 2005;202:541-549. (Pubitemid 41186952)
20. Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol. 2007;120:238-244.
21. Seshasayee D, Lee WP, Zhou M, Shu J, Suto E, Zhang J, et al. In vivo blockade of OX40 ligand inhibits thymic stromal lymphopoietin driven atopic inflammation. J Clin Invest. 2007; 117:3868-3878.
22. Kagami S, Saeki H, Tsunemi Y, Nakamura K, Kuwano Y, Komine M, et al. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli. Eur J Immunol. 2008;38:647-657.
23. Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Asano N, Mitsui H, et al. Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol. 2003;111:592-597. (Pubitemid 36337882)
24. Schallreuter KU, Wood JM, Lemke R, LePoole C, Das P, Westerhof W, et al. Production of catecholamines in the human epidermis. Biochem Biophys Res Commun. 1992;189:72-78.
25. Schallreuter KU, Wei Y, Pittelkow MR, Swanson NN, Gibbons NC, Wood JM. Structural and functional alterations in the beta2- adrenoceptor are caused by a point mutation in patients with atopic eczema. Exp Dermatol. 2007;16:807-813. (Pubitemid 47377645)
26. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol. 1993;8:334-339.
27. Schallreuter KU. Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis. J Investig Dermatol Symp Proc. 1997;2:37-40.
28. Maestroni GJ. Sympathetic nervous system influence on the innate immune response. Ann N Y Acad Sci. 2006;1069:195-207. (Pubitemid 43989862)
29. Wessler I, Reinheimer T, Kilbinger H, Bittinger F, Kirkpatrick CJ, Saloga J, et al. Increased acetylcholine levels in skin biopsies of patients with atopic dermatitis. Life Sci. 2003;72:2169-2172. (Pubitemid 36298963)